Roberts E F, Chen K W, Brown S R. "一种的合成方法" [P]. US Patent, US 10380448 B2, 2025-04-16.
Schröder R, Lefèvre J P, Johansson L. "Method for the Synthesis of (1R)-1-(5-Methylpyrazin-2-yl)-2,5-diazabicyclo[2.2.1]heptane" [P]. European Patent, EP 3917389 A1, 2015-12-04.
发明人李文辉,徐明华,唐晓军. "A Process for Preparing High-Purity (1R)-1-(5-Methylpyrazin-2-yl)-2,5-diazabicyclo[2.2.1]heptane" [P]. 中国发明专利, 专利号 CN 116232412 B, 授权公告日 2018-02-04.
参考文献 Literature
Brown R C, Davis S M. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Rapid Commun. Mass Spectrom., 2016, 357, (6), 4880-4898.
Zhou X P, Huang L, Wu G. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Food Chem., 2014, 2282, 1231-1243.
Zhang Y, Li Q, Chen T. "Identification and Structural Characterization of a Novel Degradation Product of (1R)-1-(5-Methylpyrazin-2-yl)-2,5-diazabicyclo[2.2.1]heptane Using HRMS and NMR". Biomed. Chromatogr., 2021, 1846, 9207-9224.
Yang F, Sun W, Liu J. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Talanta, 2024, 2243, 5466-5486.